| ADL | adalimumab |
| AAA | Anti-adalimumab antibodies |
| SPR | Surface plasmon resonance |
| TNF-α | Tumor necrosis factor-alpha (TNF-α) |
| FDA | Food and Drug Administration |
| EMA | European Medicines Agency |
| JIA | Juvenile Idiopathic Arthritis |
| NHS | N-hydroxysuccinimide |
| EDC | 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide |
| RU | Resonance Units |
| MTX | Methotrexate |